↓ Skip to main content

Effects of fucoidan from Fucus vesiculosus in reducing symptoms of osteoarthritis: a randomized placebo-controlled trial

Overview of attention for article published in Biologics: Targets & Therapy, May 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)

Mentioned by

twitter
1 X user
patent
1 patent
facebook
1 Facebook page

Readers on

mendeley
89 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Effects of fucoidan from Fucus vesiculosus in reducing symptoms of osteoarthritis: a randomized placebo-controlled trial
Published in
Biologics: Targets & Therapy, May 2016
DOI 10.2147/btt.s95165
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 10 11%
Student > Master 8 9%
Student > Ph. D. Student 7 8%
Other 5 6%
Student > Doctoral Student 4 4%
Other 13 15%
Unknown 42 47%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 10 11%
Medicine and Dentistry 10 11%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Biochemistry, Genetics and Molecular Biology 5 6%
Nursing and Health Professions 4 4%
Other 9 10%
Unknown 45 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2025.
All research outputs
#11,188,949
of 33,940,276 outputs
Outputs from Biologics: Targets & Therapy
#162
of 375 outputs
Outputs of similar age
#117,564
of 335,006 outputs
Outputs of similar age from Biologics: Targets & Therapy
#2
of 3 outputs
Altmetric has tracked 33,940,276 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 375 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 335,006 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.